ESR1 and breast carcinoma: Although stimulation of Brn-3b promoter activity by the hormone oestrogen via ERα is likely to act independently and possibly, in parallel with growth factor-mediated promoter activation via the p42/p44 MAPK signalling, there is also significant "cross-talk" between these pathways in breast cancer cells.